Versant Venture Management as of Dec. 31, 2017
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Audentes Therapeutics | 39.6 | $38M | 1.2M | 31.25 | |
| Achaogen | 14.5 | $14M | 1.3M | 10.74 | |
| Ocular Therapeutix (OCUL) | 10.4 | $9.9M | 2.2M | 4.45 | |
| Cymabay Therapeutics | 10.2 | $9.6M | 1.0M | 9.20 | |
| Immune Design | 9.1 | $8.6M | 2.2M | 3.90 | |
| Second Sight Med Prods | 9.0 | $8.6M | 4.5M | 1.91 | |
| Clovis Oncology | 7.3 | $6.9M | 102k | 68.00 |
